Stockreport

Proteostasis stock rises 22% on FDA designation, smaller-than-expected Q4 loss [MarketWatch]

PROTEOSTASIS THERAPEUTICS  (PTI) 
Last proteostasis therapeutics earnings: 3/10 04:36 pm Check Earnings Report
US:NYSE Investor Relations: ir.proteostasis.com/investor-overview
PDF Proteostasis stock rises 22% on FDA designation, smaller-than-expected Q4 loss Proteostasis Therapeutics Inc. PTI, +24.10% shares rose 22% in premarket trade Thursday [Read more]